Credit: Pixabay/CC0 Public Domain
Discover the reasons why people are not persisting with newer generation anti-obesity drugs, known as GLP-1 receptor agonists, and Wegovy. A new study, published in the journal Obesity showed that only 44% of people prescribed weight-loss drugs were still taking them after three months and 19% after one year.
Learn how greater adherence to these drugs, such as Wegovy, which make you feel fuller faster and longer, is associated with greater weight loss. Why do people not persist with it?
Actually, it’s not that unusual. Not persisting with medication is a well-known phenomenon with other conditions, such as type 2 diabetes, chronic obstructive pulmonary disease and hypertension. Studies have shown that by the end of one year, almost half of the people on blood pressure pills stop taking them.
Find out what factors influence the willingness to keep taking medication and how the side-effects of GLP-1 drugs compare with other weight loss drugs.
Discover the importance of GLP-1 dosing frequency and why persistence with GLP-1 drugs appears much greater than with other weight loss drugs.
Find out about the potential side-effects of GLP-1 medication to better understand why people are stopping treatment.
Learn more about the clinical trials conducted on GLP-1 drugs and how a well-reported global shortage of GLP-1 drugs is affecting patients.
What happens when people stop taking the drug? » …
Read More rnrn
